No generic Levemir (insulin detemir) is currently available. Several patents prevent any generic versions from being sold in the United States until February 2014, when the first patent expires. Also, Levemir is considered a "biologic" medication, which means it is under different laws and regulations than many other medications. At this point, it is not legal for generic Levemir to be manufactured.
Levemir Generic: An OverviewLevemir® (insulin detemir) is a prescription diabetes medication. It is a long-acting form of insulin that is approved to treat both type 1 and type 2 diabetes.
Levemir is made by Novo Nordisk. At this time, generic Levemir has not been approved in the United States.
When Will Generic Levemir Be Available?This is a difficult question to answer. There are at least two major obstacles preventing generic Levemir from becoming available. First, several unexpired patents protect the drug. The first of these patents is currently set to expire in February 2014.
Second, Levemir is considered a "biologic" medication and is, therefore, under different rules and laws than most other medications. At this point, generic biologics, including generic Levemir, are not allowed to be manufactured in the United States. Currently, legislation is under way that may change the laws concerning generic biologics (including insulin), but it is not clear when (or even if) this may happen.
Is Insulin Detemir the Same as Generic Levemir?No -- insulin detemir is the active ingredient in Levemir, but is not a generic version of it. What can be confusing is that, oftentimes, the active ingredient of a drug is referred to as the "generic name." The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.